Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to advise that results ...
Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a ...
Atrial fibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that ...
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston. In ...
Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for ...
Sunburn has traditionally been attributed to UV-induced DNA damage. However, a new study by the University of Copenhagen and Nanyang ...
Scientists at Children's Medical Research Institute (CMRI) have solved a big mystery in cancer research – why cells die in ...
New findings reveal how contemporary H5N1 avian flu viruses adapt to suppress human immune responses, leading to milder illness but ...
Researchers are shining a light on cancer cells' energy centers – literally – to damage these power sources and trigger ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net